Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Cyclin A RxL substrate-binding groove, also known as the hydrophobic patch or recruitment site, is a specialized protein-protein interaction surface located on Cyclin A2 (CCNA2). This groove is characterized by a conserved MRAIL sequence that recognizes and binds to the RxL (Arg-x-Leu) motif found in various cell cycle substrates and regulators, including E2F1, p21, and p27 (nih.gov, 1.1.1, 1.1.2). By facilitating these interactions, the groove enables the Cyclin A-CDK2 complex to phosphorylate specific targets required for DNA replication during S-phase and the subsequent transition into mitosis (wikipedia.org, 1.3.1). In many cancers, particularly those with RB1 or TP53 mutations, the G1-S checkpoint is compromised, leading to dysregulated and high E2F activity (biorxiv.org, 1.2.4). Therapeutic targeting of this groove with macrocyclic peptides or small molecules, such as CID-078, competitively inhibits substrate recruitment, paradoxically hyperactivating E2F1 and inducing mitotic catastrophe (cancer.gov, 1.2.3). This mechanism provides a synthetic lethal approach for treating E2F-driven malignancies like small-cell lung cancer while maintaining a therapeutic window relative to normal cells (nih.gov, 1.2.1).
Competitive inhibition of RxL-motif substrate binding to Cyclin A2, leading to E2F1 hyperactivation and disruption of the Cyclin B-Myt1 interaction, which triggers the spindle assembly checkpoint and apoptotic cell death.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclin-A2 RxL substrate-binding groove (CCNA2 RxL groove).